A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

Clinical trial NCT07667803 · RECRUITING

Trial details

NCT number: NCT07667803
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Weight Management

Start date: 2026-06-29
Primary completion: 2028-07-31
Enrollment: 4500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.